Prophylactic Magnesium Sulfate and Sepsis in Preterm neonates

Prophylactic Magnesium Sulfate and Sepsis in Preterm neonates with Respiratory Distress Syndrome

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080901001162N28

Enrollment

194

Registered

2024-07-20

Start date

2024-05-20

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory distress syndrome. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Intervention group: For five days, half a milliequivalent of magnesium sulfate per kilogram of body weight is given intravenously. Intervention 2: Control group: Their diet consists o

Eligibility

Sex/Gender

All

Age

1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Premature newborns 28 to 34 weeks weighing 1200 to 2000 grams with respiratory distress syndrome Informed consent

Exclusion criteria

Exclusion criteria: Intake of magnesium sulfate by the mother during pregnancy Neonatal anomaly Chorioamnionitis Mother's disease

Design outcomes

Primary

Measure	Time frame
The days requiring assisted ventilation ( need for invasive or non-invasive assisted ventilation). Timepoint: During the hospitalization of the newborn. Method of measurement: daily It is done only through a mask that is firmly placed on the face.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ashraf Mohammadzadeh

Mashhad University of Medical Sciences

Mohamadzadeha@mums.ac.ir+98 51 3852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026